Hypoxia-Inducible Factor-1α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 Gene
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
CX3CR1 is an important chemokine receptor and regulates the chemotactic migration of pancreatic ductal adenocarcinoma (PDAC) cells. Up to now, its regulatory mechanism remains largely undefined. Here, we report that hypoxia upregulates the expression of CX3CR1 in pancreatic cancer cells. When hypoxia-inducible factor (HIF)-1α expression was knocked down in vitro and in vivo, the expression of CX3CR1 was significantly decreased. Chromatin immunoprecipitation assay demonstrated that HIF-1α bound to the hypoxia-response element (HRE; 5'-A/GCGTG-3') of CX3CR1 promoter under normoxia, and this binding was significantly enhanced under hypoxia. Overexpression of HIF-1α significantly upregulated the expression of luciferase reporter gene under the control of the CX3CR1 promoter in pancreatic cancer cells. Importantly, we demonstrated that HIF-1α may regulate cancer cell migration through CX3CR1. The HIF-1α/CX3CR1 pathway might represent a valuable therapeutic target to prevent invasion and distant metastasis in PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it was recently found that HIF-1α is overexpressed in pancreatic cancer even under normoxia condition and levels of HIF-1α are positively correlated with tumor progression, angiogenesis, cell migration and poor prognosis [7, 8, 10, 11].”
From Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma (2015) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013 · cited 1×
“The sole ligand for CX3CR1 is the chemokine CX3CL1, also named Fractalkine/Neurotactin [5,6].”
BackgroundDefining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445 · cited 1×
“CX3CR1 is normally expressed by hematopoetic cells [1], prostate cancer [2], breast cancer [3] and pancreatic ductal adenocarcinoma (PDAC) [4].”
BackgroundHou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., Dong, Q., Qin, L., Wu, X., Zheng, Y., Yang, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.001 · Cited by 690 · cited 1×
“1 ml saline buffer was injected into tumor mass once every 3 days for 3 weeks [19].”
MethodNeurotactin, a membrane-anchored chemokine upregulated in brain inflammation
Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-A., Vath, J., Gosselin, M., Ma, J., Dussault, B., et al. (1997) · Nature · doi:10.1038/42491 · Cited by 644 · cited 1×
“The sole ligand for CX3CR1 is the chemokine CX3CL1, also named Fractalkine/Neurotactin [5,6].”
BackgroundChemokines, neuronal–glial interactions, and central processing of neuropathic pain
Gao, Y.-J., & Ji, R.-R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.002 · Cited by 627 · cited 1×
“Neuropathic pain is a common phenomenon in PDAC patients [10].”
BackgroundOxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy
VAUPEL, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90210-6 · Cited by 479 · cited 1×
“The hypoxic condition was defined to mimic the average oxygen tension in tumors reported previously [20].”
BackgroundVerge, G. M., Milligan, E. D., Maier, S. F., Watkins, L. R., Naeve, G. S., & Foster, A. C. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03593.x · Cited by 386 · cited 1×
“CX3CL1 is defined as a membrane as well as a soluble chemokine expressed by neurons and activated endothelial cells [7,8].”
BackgroundFractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
Fraticelli, P., Sironi, M., Bianchi, G., D’Ambrosio, D., Albanesi, C., Stoppacciaro, A., Chieppa, M., Allavena, P., Ruco, L., Girolomoni, G., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11517 · Cited by 321 · cited 1×
“The conditioned supernatants were collected [4,18].”
Cited by
Tumor microenvironment participates in metastasis of pancreatic cancer
Ren, B., Cui, M., Yang, G., Wang, H., Feng, M., You, L., & Zhao, Y. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0858-1 · Cited by 589
“Hypoxia plays a critical role in pancreatic cancer progression by inducing HIF1 to activate numerous genes involved in invasion and metastasis, such as NF-κB [136], MMP-2 [137, 138], quiescin-sulfhydryl-oxidase-1 (QSOX1) [139], CX3CR1 [140], and lysyl-oxidase (LOX) [141].”
BackgroundTargeting hypoxic tumor microenvironment in pancreatic cancer
Tao, J., Yang, G., Zhou, W., Qiu, J., Chen, G., Luo, W., Zhao, F., You, L., Zheng, L., Zhang, T., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01030-w · Cited by 412
“Moreover, ROS-mediated activation of p38 MAPK is involved in stabilizing HIF-1α via phosphorylation of HIF-1α which inhibits its ubiquitination and degradation [79, 80].”
BackgroundZhao, X., Li, F., Li, Y., Wang, H., Ren, H., Chen, J., Nie, G., & Hao, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.028 · Cited by 247
Self-citationHypoxia-regulated target genes implicated in tumor metastasis
Tsai, Y.-P., & Wu, K.-J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-102 · Cited by 190
“Similar regulation of another chemokine receptor, chemokine (C-X3-C motif ) receptor 1 (CX3CR1), is also shown in prostate cancer and pancreatic ductal adenocarcinoma cells to mediate their migration and invasion [41,42].”
BackgroundZhao, X., Gao, S., Ren, H., Sun, W., Zhang, H., Sun, J., Yang, S., & Hao, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3009 · Cited by 163
“siRNAs against HIF-1a and pcDNA-HIF-1a plasmids were prepared as previously described (4, 16).”
MethodSelf-citationThe role of hypoxia in pancreatic cancer: a potential therapeutic target?
Erkan, M., Kurtoğlu, M., & Kleeff, J. H. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1117386 · Cited by 165
“These include NF-κB,[83] membranetype-2 matrix metalloproteinase,[89,90] quiescin-sulfhydryl-oxidase-1 (QSOX1),[91] chemokine (C-X3-C motif) receptor-1 (CX3CR1),[92] and lysyl-oxidase (LOX).”
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2948 · Cited by 142
Self-citationFractalkine/CX3CL1 in Neoplastic Processes
Korbecki, J., Simińska, D., Kojder, K., Grochans, S., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103723 · Cited by 116
“The CX3CR1 gene promoter has hypoxia response elements [139], which allows HIF-1 to bind to these sequences in hypoxia, thus increasing the expression of CX3CR1.”
BackgroundLASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer
Zhao, T., Ren, H., Li, J., Chen, J., Zhang, H., Xin, W., Sun, Y. K., Sun, L., Yang, Y., Sun, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2040 · Cited by 113
Self-citationLi, N., Li, Y., Li, Z., Huang, C., Yang, Y., Lang, M., Cao, J., Jiang, W., Xu, Y., Dong, J., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060799 · Cited by 93
“SiRNAs against HIF-1α and pcDNA-HIF-1α plasmids were used as previously described [10].”
BackgroundMethodSelf-citationTargeting hypoxic response for cancer therapy
Paolicchi, E., Gemignani, F., Krstic-Demonacos, M., Dedhar, S., Mutti, L., & Landi, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7229 · Cited by 88
“Furthermore, ADM is overexpressed in RCC [72] and in PDAC [73]).”
InfluentialLi, W., Cao, L., Chen, X., Lei, J., & Ma, Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4504 · Cited by 88
Kim, Y.-E., Lee, M., Gu, H., Kim, J., Jeong, S., Yeo, S., Lee, Y. J., Im, S., Sung, Y., Kim, H. J., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033241 · Cited by 87
“CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.”
BackgroundInfluentialYe, L., Zhang, Q., Bai, X., Prasoon, P., Hu, Q., & Liang, T. (2014) · Pancreatology · doi:10.1016/j.pan.2014.06.008 · Cited by 74
ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin
Zhao, T., Jiang, W., Wang, X., Wang, H., Zheng, C., Li, Y., Sun, Y. K., Huang, C., Han, Z.-B., Yang, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2170 · Cited by 59
“A Dual-Luciferase Reporter Assay System (Promega) was used to measure the luciferase activity in transfected cells as described previously (3,39).”
MethodSelf-citationRen, H., Jia, L., Zhao, T., Zhang, H., Chen, J., Yang, S.-G., Liu, J., Yu, M., & Hao, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.001 · Cited by 48
Self-citationWang, X., Ren, H., Zhao, T., Ma, W., Dong, J., Zhang, S., Xin, W., Yang, S., Jia, L., & Hao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7263 · Cited by 48
“We have previously demonstrated that overexpression of HIF-1α is associated with advanced tumor stages in patients with PDAC [5, 6, 19-22] and proposed that HIF-1α is an attractive target for the development of anticancer agents [23-25].”
BackgroundSelf-citationSingh, S. K., Mishra, M. K., & Singh, R. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0517-1 · Cited by 45
Erreni, M., Siddiqui, I., Marelli, G., Grizzi, F., Bianchi, P. P., Morone, D., Marchesi, F., Celesti, G., Pesce, S., Doni, A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501335 · Cited by 47
“pancreatic cancer (47, 48), a finding that we did not confirm (21) (and data not shown).”
BackgroundKDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway
Liao, Z., She, C., Ma, L., Sun, Z., Li, P., Zhang, X., Wang, P., & Li, W. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00715-2 · Cited by 45
The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment
Zhou, J., Xiang, Y., Yoshimura, T., Chen, K., Gong, W., Huang, J., Zhou, Y., Yao, X., Bian, X., & Wang, J. (2014) · BioMed Research International · doi:10.1155/2014/751392 · Cited by 46
Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma
Lang, M., Wang, X., Wang, H., Dong, J., Lan, C., Hao, J., Huang, C., Li, X., Yu, M., Yang, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.016 · Cited by 45
Self-citationStructure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
Lu, X. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220629140540 · Cited by 41
Wu, Y., Meitzler, J. L., Antony, S., Juhasz, A. N., Lu, J., Jiang, G., Liu, H., Hollingshead, M. G., Haines, D. C., Butcher, D. O., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12032 · Cited by 41
Weiss, I. D., Huff, L. M., Evbuomwan, M. O., Xu, X., Dang, H. D., Velez, D. S., SINGH, S. P., Zhang, H. H., Gardina, P. J., Lee, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19945 · Cited by 42
“Just as for CXCR4, CX3CR1 is up-regulated by the hypoxia-responsive transcription factor, HIF-1 α [68].”
BackgroundSong, Z., Ren, H., Gao, S., Zhao, X. L., Zhang, H., & Hao, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2452-5 · Cited by 39
Self-citationThe promising role of miR-296 in human cancer
Zhu, L., Deng, H., Hu, J., Huang, S., Xiong, J., & Deng, J. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.09.026 · Cited by 39
miRNA-296-3p modulates chemosensitivity of lung cancer cells by targeting CX3CR1.
Luo, W., Lin, Y., Meng, S., Guo, Y., Zhang, J., & Zhang, W. (2016) · PubMed Central · Cited by 34
HIF-1 is a critical target of pancreatic cancer
Hao, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1026535 · Cited by 38
“Importantly, HIF-1 regulated pancreatic cancer cell migration and the process of neurotropism via CX3CR1.(3) While exploring the axis of CX3CL1/ CX3CR1, we found that the CX3CL1/ CX3CR1 pair can activate the MAPK and PI3K/Akt signaling pathways.”
BackgroundSelf-citationWei, P., Jiang, W., Chen, W., Sun, W., & Fu, X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.6.3613 · Cited by 30
“A developing body of evidences has shown that hypoxia inducible factor-1α (HIF-1α) is involved in crucial aspects of cancer biology, including angiogenesis, proliferation, energy metabolism and invasion (Hiraki et al., 2012; Schito et al., 2012; Zhao et al., 2012; Cheng et al., 2013).”
BackgroundGadepalli, A., Akhilesh, A., Uniyal, A., Modi, A., Chouhan, D., Ummadisetty, O., Khanna, S. A., Solanki, S., Allani, M., & Tiwari, V. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00414 · Cited by 30
Wang, H., Jia, R., Zhao, T., Li, X., Lang, M., Lan, C., Wang, H., Li, Z., Zhou, B., Wu, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.036 · Cited by 23
Self-citationRetractedZoa, A., Yang, Y., Huang, W., Yang, J. L., Wang, J., Wang, H., Dong, M., & Tian, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-787 · Cited by 24
Targeting the hypoxia pathway to treat pancreatic cancer
Zhang, J., Erickson, L. A., Highsmith, E. W., & Fei, P. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s80888 · Cited by 32
“The crosstalk between HIF-1 and CX 3 CR 1 mediated perineural invasion 6 and the Warburg effect of PDAC.”
Li, D., Liu, J., Zhang, W., Ren, J., Yan, L., Liu, H., & Xu, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063445 · Cited by 20
“The protein encoded by the hypoxia-inducible factor-1 alpha (HIF1A) gene is a key transcription factor found in cells growing at low oxygen concentrations, which regulates cellular responses, adaption and survival under hypoxia in physiology and pathological processes [3,4] via the increased transcription of several d…”
BackgroundSelf-citationFunctions of chemokines in the perineural invasion of tumors (Review)
Zhang, M., Zhu, Z.-L., Gao, X., Wu, J., Liang, X., & Tang, Y. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4311 · Cited by 21
“In prostate cancer and pancreatic ductal adenocarcinoma, cancer invasion and metastasis is closely associated with the CX3CR1 expression of tumor cells, which is induced by hypoxia, and the ligand CX3CL1 is mainly expressed at the site of metastasis (128,129).”
Ren, H., Zhao, T., Sun, J., Wang, X., Liu, J., Gao, S., Yu, M., & Hao, J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24608 · Cited by 20
“Although we recently confirmed that HIF‐1a directly transactivated CX3CR1 [Zhao et al., 2012], the rapid increase of CX3CR1 could not be explained by the secondary response to HIF‐1a up‐regulation.”
BackgroundSelf-citationZhang, D., Lei, J., Ma, J., Chen, X., Sheng, L., Jiang, Z., Nan, L., Xu, Q., Duan, W., Wang, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5677 · Cited by 23
“The expression of HIF-1α was correlated with tumor characteristics, microvascular density (MVD) and survival [40–42].”
Liao, C., Zheng, C., & Wang, L. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13286 · Cited by 17
Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Leppänen, J., Helminen, O., Huhta, H. I., Kauppila, J. H., Isohookana, J., Haapasaari, K., Parkkila, S., Saarnio, J., Lehenkari, P. P., & Karttunen, T. J. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1432-4 · Cited by 12
“…et al. 2013 129 Bond™ Polymer Refine Detection Kit, no negative control mentioned BD Biosciences No High nuclear HIF-1alpha ➔ poor overall survival [15] Zhao et al. 2012 95 Streptavidin biotin-peroxidase, biotinylated secondary antibody, no negative control mentioned sc-10790, Santa…”
BackgroundASAP3 is a downstream target of HIF-1α and is critical for progression of lung adenocarcinoma
Zhang, P., Sun, J., Kai, J., Peng, Y., Liu, X., Zhou, F., & Wu, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s199603 · Cited by 8
“Forty-eight hours later, cells were then collected and analyzed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega) as described.(17) Results were expressed as a fold induction relative to the cells transfected with the control vector (pcDNA3.”
MethodSong, Z., Ren, H., Gao, S., Zhao, T., Wang, X., Zhang, S., Zhao, X. L., Jia, L., Sun, J., & Hao, J. (2013) · Medical Oncology · doi:10.1007/s12032-013-0756-8 · Cited by 4
Self-citationRetractedThe Role of HIF1-related Genes and Non-coding RNAs Expression in Clear Cell Renal Cell Carcinoma
GRAMMATIKAKI, S., Katifelis, H., STRAVODIMOS, K. G., BAKOLAS, E., Kavantzas, N., GRIGORIADOU, D., & Gazouli, M. (2023) · In Vivo · doi:10.21873/invivo.13185 · Cited by 3
Chirumbolo, S. (2015) · PubMed Central · doi:10.12865/chsj.41.01.01 · Cited by 2
“Therefore, a possible hypothesis on the HIF-1α/CX3CR1 axis in pacreatic cancer, is that PDA cells express CX3CR1, usually upregulated by calcitriol induced macrophages, probably to escape to immune surveillance and response.”
BackgroundNovel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Li, Z., Li, W., Dong, Y., & Sun, X. (2019) · Clinical Cancer Drugs · doi:10.2174/2212697x06666190328180331 · Cited by 1
Song, Z., Ren, H., Gao, S., Zhao, T., Wang, X., Zhang, S., Zhao, X. L., Jia, L., Sun, J., & Hao, J. (2015) · Medical Oncology · doi:10.1007/s12032-014-0436-3
Self-citationSongHe, Z., GaoTiansuo, R., Wang, Z., & ZhangXiao, S. (2013)
Scutellarin Alleviates Neuronal Apoptosis After Ischemia and Hypoxia via the HIF‐1α–CX3CR1 Axis
Pei, J., Hu, B., Wen, Z., Wan, C., Zhang, F., Li, S., Wang, L., Li, Z., & Tang, Z. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71098
“HIF-1α may regulate cancer cell migration through CX3CR1 [26].”
Self-citation
Metadata
- Authors
- Zhao, T., Gao, S., Wang, X., Liu, J., Duan, Y., Yuan, Z., Sheng, J., Li, S., Wang, F., Yu, M., Ren, H., & Hao, J.
- Affiliations
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tianjin University (CN)
- Tianjin Nankai Hospital (CN)
- Corresponding author
- Ren, He
- Hao, Jihui
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-27
- Volume
- 7
- Issue
- 8
- Pages
- e43399
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3428361
- OpenAlex
- W2011803416
- Cited by
- 48
- References
- 22
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 7 · 2015: 9 · 2014: 7 · 2013: 5 · 2012: 1
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (30973490, 30900596, 30901448, 81172355)
- China Postdoctoral Science Foundation (20090450773)
- Natural Science Foundation of Tianjin City (81172355)
- Program for New Century Excellent Talents in University
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- hypoxia-inducible factor-1α, CX3CR1, pancreatic ductal adenocarcinoma, chemotactic migration, hypoxia, chemokine receptors, transcriptional regulation, hypoxia response element, promoter binding, metastasis, therapeutic target
- MeSH terms
- CX3C Chemokine Receptor 1, Adenocarcinoma, Animals, Hypoxia, Chemotaxis, Chromatin, Female, Flow Cytometry, Gene Expression Regulation, Humans, Ligands, Mice, Nude, Neoplasm Metastasis, Pancreatic Neoplasms, Promoter Regions, Genetic, Microscopy, Confocal, Receptors, Chemokine, Carcinoma, Pancreatic Ductal, RNA, Small Interfering, Cell Line, Tumor, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.